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Background: The nuclear factor kappa-B (NF-κB) is a major transcription factor respon-
sible for the production of numerous inflammatory mediators, including the tumor necrosis 
factor (TNFα), which has a lethal association with cancer’s onset. The silver nanoparticles 
(AgNPs) are widely used in cancer treatment and several other biomedical applications.
Objective: The study aimed to determine the effects of silver citrate nanoparticles (AgNPs- 
CIT) on NF-κB activation together with TNFα mRNA/protein expressions in the phorbol 
myristate acetate (PMA)-stimulated MCF-7 human breast cancer cell-lines.
Methods: The AgNPs-CIT were synthesized by the reduction method, and the prepared 
AgNPs-CIT were characterized for their shape, absorption in UV-VIS electromagnetic 
radiations, size distribution, ζ-potential, and antioxidant activity. The MCF-7 cell-lines 
were pretreated with AgNPs-CIT and stimulated with PMA. The TNFα mRNA expressions 
were determined by real-time PCR, whereas the protein production was determined by the 
ELISA. The NF-κB activity was distinctly observed by highly-specific DNA-based ELISA, 
and by NF-κB-specific inhibitor, Bay 11–7082.
Results: The prepared AgNPs-CIT were spherical and have an absorption wavelength range of 
381–452 nm wherein the particles size ranged between 19.2±0.1 to 220.77±0.12 nm with the 
charge range −9.99±0.8 to −34.63±0.1 mV. The prepared AgNPs-CIT showed comparative 
antioxidant activity at >40% inhibitions level of the DPPH radicals. The AgNPs-CIT were 
found to be non-toxic to MCF-7 cell- 
lines and inhibited PMA-induced activation of the NF-κBp65, and also the mRNA/protein 
expression of TNFα.
Conclusion: This is the first report that showed AgNPs-CIT inhibited TNFα expression via 
deactivation of the NF-κB signaling event in stimulated breast cancer cells. The results have 
important implications for the development of novel therapeutic strategies for the prevention/ 
treatment of cancers and/or inflammatory disorders.
Keywords: phorbol myristate acetate, PMA, TNFα, NF-κB, silver citrate nanoparticles, 
MCF-7 cell lines, cancer, inflammatory cytokines
Introduction
The advent of silver nanoparticles (AgNPs) in cancer theranostics has been unprece-
dented in the last two decades. The cancer nanomedicine has primarily been derived by 
the gold and silver nanostructures, whereby silver metal-based capped biogenic, and 
redox-methods based nano-entities preparations, and their applications in various 
oncogenic chemotherapeutic interventions have provided the needed impetus to the 
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silver nanoparticles as the leading nanomedicine part of the 
cancer chemotherapy.1 The use of AgNPs has also been 
preferred on account of its ease availability, cost-effective 
preparation, and compatible toxicological behavior. AgNPs 
of different sizes, capping, charge, polydispersity index 
(PDI), and yields-density have been prepared through var-
ious biogenic, chemical as well as other in situ, and physical 
approaches.2 The necessity and advancements of AgNPs 
preparation and capping variations have opened up newer 
vistas in cancer treatment. The genomic and proteomic sup-
ported changes in various aspects of oxidative stress controls 
in cancerous cells.3
Studies on cellular and systemic toxicity were under-
taken, and it is reported that the AgNPs-CIT is not harm-
ful, and are not considered toxic within cells.4 Further, 
studies also demonstrated that the AgNPs-CIT can inhibit 
the PMA (phorbol 12-myristate 13-acetate) in monocytes 
through down-regulating both the expression of surface 
marker CD11b and reaction to lipopolysaccharide (LPS) 
stimulation.5 The AgNPs-CIT has also has been shown to 
possess antitumor properties for Dalton’s lymphoma 
ascites (DLA), both in vitro and in vivo conditions by 
activation of the caspase-3 enzyme, which led to curative 
effects in the tumor-borne mice by decreasing the weight 
and tumor volume.6 More functional details and applica-
tions feasibility studies of these AgNPs genre have lately 
been appearing. In this connection, to deal with tumor 
suppression through various biochemical and physiologi-
cal processes and conditions, the role of the tumor necrosis 
factor-alpha has also been judged crucial wherein the 
tumor necrosis factor-alpha (TNFα), a cytokine, generates 
acute stage reaction and is produced mainly by the stimu-
lation of the macrophages, although it can also be gener-
ated by several other cell forms, eg, CD4+ lymphocytes, 
mast cells, neutrophils, eosinophils, and the neurons.7
The primary function of the TNFα is to control the 
immune cells. The TNFα is an endogenous pyrogen, and is 
capable of causing fever, cell-death through apoptosis, auto-
nomic dysfunctions, inflammation, and inhibition of tumor-
igenesis, as well as viral replications, and reacting to sepsis 
through IL1 and IL6 producing cells. The TNFα output 
dysregulation has been implicated in several human dis-
eases, including neurodegenerative disorders, including 
Alzheimer’s disease.8 It can also cause major depression,7 
several types of cancers,9 and inflammatory bowel disease, 
owing to the increased levels of TNFα.10 The TNFα also has 
a role in lethal septic shock and is recognized for the ther-
apeutic effects of the monoclonal anti-TNF antibodies.11 
The TNFα can also stop the death/apoptosis of neuronal 
cells by activating the transcription factor, NF-kappa-B, 
which causes the expressions of Mn-SOD (Mn-Super 
Oxide Dismutase), and Bcl-2.12 It has been reported that 
the TNFα is elevated in the blood serum of patients with 
cancer physiology. The TNFα has also been associated with 
several metastases, eg, breast cancer,13 non-small cell lung 
cancer (NSCLC),14 colon cancer,15 and leukemic cells.16 
Moreover, the high levels of TNFα were observed owing 
to the activation of NF-κB,17 which has an established and 
critical role in the inflammation, and carcinogenesis.18 
A significant relationship between the expressions of the 
TNFα and the putative TNFα inducible NF-κB related 
genes in human breast cancer was found.19 Ben-Baruch, 
2003, found that the positive TNFα expression rate is related 
to that of the presence of NF-κB in the MCF-7 cell-lines.20
The PMA is a potent tumor promoter and is frequently 
used to activate the signal transduction enzyme protein kinase 
C (PKC).21 Successively, the PMA can also activate the NF- 
κB-dependent transcription with negligible effects on the 
DNA binding. Furthermore, the extremely effective concen-
trations of both the TNFα and PMA can produce an improving 
effect on the NF-κB-dependent transcription.22 Nonetheless, 
the superoxide radical was recognized as the major responsive 
oxygen species generated by the PMA in mouse 
macrophages.23 In this context, the PMA has regularly been 
used as an inducer for endogenous superoxide productions,24 
and it has also been used to stimulate the B-cells divisions 
throughout the cytogenetic diagnosis of B-cell cancers, ie, 
chronic lymphocytic leukemia.25 The nuclear factor kappa-B 
(NF-kB) family genes play vital roles in tumor growth, tissue 
development, metastasis, and decreased apoptosis.26,27 Due to 
the inhibition of NF-kB, it can be taken as a potential pharma-
cological target for controlling the cancer progression, and 
further used in designing chemotherapeutic agents for onco-
logical interventions through new drug discovery and 
improved chemotherapeutic regimes. This study aimed to 
establish the roles of the TNFα, and elaborate on the controls 
of the NF-κB activation in arresting the hallmarks of cancer in 




Silver nitrate (AgNO3), tri-sodium citrate (TSC), sodium 
chloride, potassium chloride, disodium hydrogen phos-
phate, potassium dihydrogen phosphate, sodium hydroxide, 
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hydrogen peroxide, and hydrochloric acid, all chemicals 
were purchased from (VBBN company, Hong Kong, 
China). Phorbol 12-myristate 13-acetate (PMA), 2,2-diphe-
nyl-1-picrylhydrazyl (DPPH) were purchased from Sigma- 
Aldrich (St. Louis, MO). Iscove’s Modified Dulbecco’s 
medium was purchased from Invitrogen (Carlsbad, CA), 
and iron-supplemented calf serum was procured from 
HyClone Laboratories (Logan, UT). Antibodies were pur-
chased from Cell Signaling Technology Inc. (Danvers, 
MA), and Santa Cruz Biotechnology, Inc. (Santa Cruz, 
CA). NF-kB inhibitor (parthenolide) was purchased from 
Calbiochem (San Diego, CA). Kits for performing cyto-
kine-specific enzyme-linked immunosorbent assays 
(ELISAs) were purchased from R&D Systems (St. Paul, 
MN). MCF-7 cell lines were purchased from the American 
Type Culture Collection (ATCC #ATCC® 30–4500K™, 
Middlesex, UK). All the chemicals were of analytical 
grades.
Methods
Synthesis of Silver Nanoparticles Using Trisodium 
Citrate
The AgNPs-CIT were prepared by the citrate reduction 
method following the previous reported method28 with 
some modifications. Briefly, 8.5 mg of AgNO3 was dis-
solved in 50 mL of Millipore-purified water to form a 1 
mM stock solution (stock solution-I). The 6.8 mL of stock 
solution-I was diluted to 100 mL with Millipore water, and 
pH was adjusted to 8 using 10 mM NaOH solution. The 
Erlenmeyer flask containing the solution was stirred vig-
orously at ≈ 4000 rpm, and heated to 100 °C, wherein the 
temperature was adjusted using a mercury thermometer. 
The 2 mL of tri-sodium citrate (TSC) solution 38 mM 
(stock solution-II) was carefully added to the boiled solu-
tion in Erlenmeyer flask slowly and was let to continue 
boiling for another 15 min. The colorless so;ution was 
changed to yellow, pink, bright red, red, brown, and dark 
brown at 2, 4, 6, 8, 10, and 12 min respectively indicating 
the completion of the reaction after 12 min. The formed 
AgNPs-CIT had different colors from. The formed 
AgNPs-CIT were stored at room temperature in amber- 
color bottles. The particles were purified by centrifugation 
at 1000 rpm for 5 min to remove the large particulates.
UV-VIS Spectroscopy
The prepared AgNPs-CIT were synthesized at different 
time intervals, and each batch of the prepared NPs was 
recorded for the absorption spectra, and each preparation 
had a specific UV spectrum according to their colors. Five 
absorption spectra for each preparation were recorded in 
the range from 300 to 700 nm on the Uvikon-941 spectro-
photometer (Kontron Instruments GmbH, Herrenberg, 
Germany). The absorbance capacities of the samples 
were recorded in 2 cm path-length plastic cuvettes. The 
surface plasmon resonance (SPR) peaks were visible in the 
range and were drawn through excel Microsoft 2019,29 
provided as Figure 1.
Size and ζ-Potential Measurements by Dynamic Light 
Scattering (DLS) Instrument
The Malvern Zetasizer nano 6.01 (Malvern Instruments 
GmbH, Herrenberg, Germany) was used to measure the 
particle size, PDI, and the ζ-potential. The timing of sam-
pling was automatically set on the instrument. For every 
10 sub-runs, three measurements were permitted. All cal-
culations were performed, according to the literature pro-
tocol in aqueous media.29,30
Surface Morphology Using Scanning Electron 
Microscopy (SEM) Analysis
SEM morphology was performed using a JEOL JSM-550 
Scanning Electron Microscope (Jeol, Akishima, Tokyo, 
Japan) to analyze the superficial morphology of the prepared 
AgNPs-CIT. A drop of AgNPs-CIT was added on a slip- 
cover (Sputter coater, JOEL JFC-1300), was fully dried, and 
covered with a thin layer of platinum in a vacuum for 55 sec 
at 25 mÅ using a coating unit to make it electrically con-
ductive before imaging in the SEM instrument.31
Fourier Transform Infrared (FT-IR) Spectroscopy
Fourier Transform Infrared (FT-IR) spectra of TSC, 
AgNPs-CIT, and AgNO3 were recorded using (Bruker, 
OPTIK GmbH, Type: Tensor 27, Germany). The samples 
were scanned at the range of 400–4000 cm−1. For purifica-
tion of the prepared AgNPs-CIT, a solution of AgNPs-CIT 
was centrifuged at 12,500 rpm, for 20 min, and 3x washed 
with Millipore water. The dried powder was obtained after 
freeze-drying of the AgNPs-CIT sample was used for the 
FT-IR analysis.29,30
Radical Scavenging Activity
Diphenyl picrylhydrazyl (DPPH), and hydrogen peroxide 
(H2O2) were used to assay the scavenging activities of the 
AgNPs-CIT using the previously reported standard 
procedure.32 In a typical experiment, about 2 mL of 
AgNPs-CIT solution was mixed with 2 mL of 0.1 mM 
DPPH solution in methanol and incubated at 37 °C in the 
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dark for about 40 min. The absorbance was recorded 
spectrophotometrically at 517 nm using methanol as the 
blank, while the H2O2 scavenging activity of AgNPs-CIT 
was measured through the reduction of H2O2. A 0.5 mL of 
AgNPs-CIT solution was added to 0.5 mL of 40 mM H2O2 
which made up to 2 mL using 0.1 M phosphate buffer (pH 
7.2), the mixture was incubated at 30 °C for 45 min. The 
absorbance was measured spectrophotometrically at 230 
nm. The % DPPH/H2O2 radical scavenging activity was 




radical scavenging assay ¼
A0   A1ð Þ
A0
x100 
Where, A0 was the absorbance of the blank, and A1 was 
the absorbance of the treated sample.
Cell Cultures
The MCF-7 cell-lines were grown as per their instructions 
(ATCC, VA, USA). Briefly, MCF-7 cell-lines were grown in 
RPMI-1640 medium supplemented with 10% heat- 
inactivated fetal bovine serum (FBS), and 1% penicillin- 
streptomycin at 37 °C in 5% CO2 as described.33,34 The 
MCF-7 cell lines were cultured with PMA and AgNPs-CIT.
Treatment of MCF-7 Cell Lines with PMA and 
AgNPs-CIT
The PMA and AgNPs-CIT effects on the viability of the 
MCF-7 cell-lines were determined invitro. The MCF-7 cell- 
lines (1 × 106/mL) were placed in 35-mm culture dishes 
(Becton-Dickinson, Franklin Lakes, NJ, USA) in DMEM 
medium, or serum-starved for 12 hr/overnight. The MCF-7 
cell-lines were cultured without PMA, or AgNPs-CIT served 
as controls. The cells were treated with various doses of 
AgNPs-CIT (0.5 to 160 μM) for 24–48 h of the incubation, 
and the cytotoxicity was examined using the CytoTox-Glo™, 
Cytotoxicity Assay Kit (Promega, Madison, WI, USA) as 
described.35 In another set of experiments, MCF-7 cell-lines 
were pretreated with different doses of AgNPs-CIT (0.5–10 
µM) for 2 h before its stimulation with PMA (0.5 µM) 
according to the reported procedure.36,37
Quantitative Real-Time PCR
Real-time quantitative PCR was used to quantify the 
expression of mRNA with GAPDH as endogenous control 
as described in earlier reports.38,39 The total RNA was 
measured using a mirVana RNA isolation kit (catalog # 
AM1560; Ambion, Foster City, CA, USA) according to 
the manufacturer’s instructions. Total RNA (1–2 µg) was 
reverse-transcribed using the SuperScript First-Strand 
cDNA synthesis kit (Applied Biosystems, Foster City, 
CA, USA). The expression of TNFα mRNA was quantified 
by TaqMan Gene Expression Assays (Applied Biosystems). 
Real-time PCR amplification and data capture were carried 
out using the Step One Real-Time PCR System (Applied 
Biosystems). Primers used for the PCR assisted 
Figure 1 UV-VIS spectra of AgNPs-CIT reduced by TSC. The UV-VIS spectra of AgNPs-CIT showed a small redshift in the surface plasmon resonance peak for each NPs. 
Each peak represents the reduction with TSC at 2, 4, 6, 8, 10, and 12 min.
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amplification were TNFα (NM_000595: forward, 5ʹ-AGG 
ACG AAC ATC CAA CCT TCC CAA-3ʹ; reverse, 5ʹ-TTT 
GAG CCA GAA GAG GTT GAG GGT-3ʹ), and GAPDH 
(NM_002046.3: forward, 5ʹ-TCG ACA GTC AGC CGC 
ATC TTC TTT-3ʹ; reverse, 5ʹ-ACC AAA TCC GTT GAC 
TCC GAC CTT-3ʹ). The typical profile times used were, 
with an initial step of 95 °C, for 10 min, followed by 
a second step, at 95 °C for 15 sec, and 60 °C for 60 sec 
for 40 cycles with melting curve analysis. The level of 
target mRNA was normalized to the level of GAPDH, and 
compared with control (untreated sample). Data were ana-
lyzed using the ΔΔCT method.40
TNFα ELISA
The MCF-7 cell-lines were pretreated with different doses 
of AgNPs-CIT (0.5–10 µM) for 2 h before stimulation 
with PMA (0.5 µM). The TNFα present in the culture 
medium was quantified using the TNFα-specific ELISA 
according to the manufacturer’s instructions (R&D 
Systems, Minneapolis, MN, USA). ELISA kit (Cayman 
Chemicals, Ann Arbor, MI, USA) was used according to 
the instructions of the manufacturer, and the microtitre 
plate was read at 450 nm using an automatic microplate 
reader (Anthos Zenyth 3100 Multimode Detectors, 
Salzburg, Austria) as described in the literature.41
Nuclear Factor-Kappa-B Activity Assays
Inhibition of NF-κB p65 activity by AgNPs-CIT in PMA 
stimulated MCF-7 cell lines was determined using a highly 
sensitive Transcription Factor ELISA Kit according to the 
instructions of the manufacturer (catalog # ab133128, 
Abcam, MA, USA). The plate was read using an automatic 
microplate reader (Anthos Zenyth 3100 Multimode Detectors, 
Salzburg, Austria) according to the references.42,43
Results
UV-VIS Spectroscopy
During the experimental procedure upon the addition of 
TSC to AgNO3, a color change was observed. The formed 
AgNPs-CIT were primarily yellowish, and upon further 
heatings, the color changed to pink, bright red, red, 
brown, and dark brown as the solution was kept boiling. 
The AgNPs-CIT generated the SPR absorption bands,44 
and the UV-VIS spectra of AgNPs-CIT showed a redshift 
in the SPR peaks for all of the produced different colors of 
AgNPs-CIT. The obtained colors had different wave-
lengths, for all the colors, ie, yellow, pink, bright red, 
red, brown, and dark brown at 2, 4, 6, 8, 10, and 12 min 
with wavelengths of 381±1.6, 398±2, 413.5±1.5, 431±1.3, 
440±3.5, and 452±1.5 nm, respectively (Figure 1).
Size, ζ-Potential, and Surface Morphology
The differential light scattering (DLS) instrument recorded 
the particle sizes of the AgNPs-CIT (Figure 2A) as being 
19.2±0.1, 33.45±0.09, 67.77±0.1, 78.55±0.2, 120.67±0.11, 
and 220.77±0.12 nm for the yellow, pink, bright red, red, 
brown, and dark brown colored preparations, respectively, in 
agreement with the previously published results.45 The ζ- 
potentials of AgNPs-CIT were negative surface charge 
values of −10.16±0.5, −14.63±0.6, −26.17±0.3, −34.63 
±0.1, −23.5±0.9, and −9.99±0.8 mV for yellow, pink, bright 
red, red, brown, and dark brown colored preparations, 
respectively (Figure 2B). The AgNPs-CIT had spherical 
shapes with an average diameter of 500 nm as shown by 
the SEM analyses (Figure 2C). All the PDIs values were 
below 0.2, representing a stable colloidal system for all the 
AgNPs-CIT preparations.
Fourier Transform Infrared (FT-IR) 
Spectroscopy
The surface functionalization of the prepared AgNPs-CIT, 
by the citrate moieties was confirmed from FT-IR analyses 
of the samples. The FT-IR spectral analysis confirmed the 
formation of the AgNPs-CIT, wherein it exhibited a strong 
absorption band for OH stretching at 3330 cm−1. The 
hump-shaped absorption band at 1400 cm−1 in the AgNPs- 
CIT FT-IR spectrum, which is absent in the IR spectrum of 
the AgNO3, resulting from the methylenes bending of the 
citrate moieties in the AgNPs-CIT preparations indicated 
the surface-bound citrates presence around the AgNPs.46 
The peak at 1610 cm−1 was attributed to (C=O) of the 
AgNPs-CIT (Figure 3).47
The Radical Scavenging Activity
The radical scavenging activity of AgNPs-CIT was con-
firmed against both the H2O2, and DPPH with quercetin as 
the reference standard (Figure 4). The AgNPs-CIT sca-
venged the free radicals at concentrations between 
0.65–10 mg/mL. The data showed that the antioxidant 
activity of AgNPs-CIT was varying in comparison to that 
of H2O2 and quercetin from weak activity levels to mod-
erate activity levels, wherein the best antioxidant activity 
of AgNPs-CIT was found at >40% (~ 42%) radicals inhi-
bitions at 10 mg/mL concentration (Figure 4).32,48
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Figure 2 The size distribution of AgNPs-CIT; (A). The mean particle size (nm), (B). ζ-potentials (mV), and polydispersity indices of all AgNPs-CIT at 2, 4, 6, 8, 10, and 12 
min; (C). SEM image of AgNPs-CIT reduced after 10 min.
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Treatment of MCF-7 with AgNPs-CIT
The AgNPs-CIT reduced at 8 min with a bright red col-
oration of the colloidal preparation having particle size at 
78.55±0.2 nm were selected for incubation with the MCF- 
7 cell-lines. The AgNPs-CIT utilized in incubation had ζ- 
potential at −34.63±0.1 mV. This preparation had superior 
stability compared to the other preparations of the AgNPs- 
CIT because of its highest ζ-potential.49 The cancer cell- 
lines, MCF-7, were pretreated with AgNPs-CIT (0.1–160 
µM) for 2 h (Figure 5A), followed by stimulation with 
PMA (40 nM) for 24 h. The cytotoxicity of AgNPs-CIT on 
MCF-7 cell-lines after 24 h treatment was analyzed by 
using the CytoTox-Glo™-based cytotoxicity assay. The 
AgNPs-CIT cytotoxicities were checked using different 
concentrations of the AgNPs-CIT (0.1–160 µM). The 
higher concentration, 160 µM, of AgNPs-CIT was incu-
bated with the MCF-7 cell-lines for different incubation 
times, from 4 to 48 h (Figure 5B), and it showed no 
Figure 3 FT-IR spectra of silver nitrate (AgNO3), AgNPs-CIT, and TSC. The black arrows represent the citrate area in TSC and AgNPs-CIT.
Figure 4 AgNPs-CIT radical scavenging (%) activity with DPPH, and hydrogen peroxide.
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toxicity to the cells as determined by the MTT assay 
(Figure 5C).
The extent of cancer cell proliferation was significantly 
decreased when pretreated with AgNPs-CIT for 2 h and 
then stimulated with PMA for 24 h (Figure 5C; p<0.05). 
The results showed that the pretreatment of breast cancer 
cell-lines with AgNPs-CIT significantly reduced the PMA- 
induced proliferation in a dose-dependent manner 
(p<0.05).
The MCF-7 cell-lines pretreated with AgNPs-CIT (0.5 to 
10 μM) for 2 h, followed by stimulation with PMA (0.5 µM) 
for 24 h, showed no cytotoxic effects of AgNPs-CIT at the 
levels of the administered dose (p>0.05) (Figure 6A). The 
levels of TNFα mRNA were quantified by a highly sensitive, 
and specific quantitative RT-PCR method wherein the values 
were compared with the control. The results showed that the 
MCF-7 cell-lines incubated with PMA had higher levels of 
TNFα mRNA as compared to the unstimulated MCF-7 cell- 
lines (p<0.05). The TNFα mRNA levels also showed 
a marked decline (p<0.01). However, in the samples pre-
treated with PMA and incubated with AgNPs-CIT (Figure 
6B), showed significant inhibition of TNFα mRNA, while at 
the same time showed of no effect because of PMA. To 
determine whether the inhibition of gene expression also 
affected the protein levels, the culture supernatants were 
assayed for TNFα protein using TNFα-specific ELISA. 
The pretreatment with 0.5 to 10 μM AgNPs-CIT signifi-
cantly decreased the PMA-induced TNFα production in the 
culture supernatant of PMA-stimulated MCF-7 cell-lines 
(p<0.05), thus establishing the roles of the PMA and the Ag- 
NPs-CIT in the process.
The nuclear factor, NF-κB, is a typical transcription fac-
tor involved in numerous inflammatory responses, and Bay- 
11-7082 (BAY) is a well-known inhibitor of its (NF-κB) 
Figure 5 (A) Effects of AgNPs-CIT concentration (0.1–160 µM) on viability of MCF-7 cell lines. (B) Effects of AgNPs-CIT treatment time (4–48 hours) on viability of MCF-7 
cell lines. (C) Effects of AgNPs-CIT on the proliferation of PMA-stimulated MCF-7 cell lines. MCF-7 cell lines were pretreated with AgNPs-CIT NP (0.5–10 µM) for 2 hours 
before stimulation with PMA (0.5 µM). #p<0.01 versus untreated cells; @p<0.01 versus PMA alone treated MCF-7 cells.
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activity.48 In the present study, BAY was used to study the 
effect of NF-κB activation in TNFα expression at both the 
genic and protein levels through observations in the MCF-7 
cancer cell-lines under treatment with the AgNPs-CIT in 
presence of the PMA. The results showed that the treatment 
of cancer cell-lines with the BAY significantly reduced the 
mRNA (Figure 7A, p<0.05) and protein (Figure 7B, p<0.05) 
levels of the TNFα in the PMA stimulated cancer cell-lines, 
clearly indicating the involvement of increased NF-κB activ-
ity in the PMA-induced expression of TNFα. Moreover, the 
involvement of NF-κB enhanced activity was further con-
firmed by the direct estimation of NF-κB levels in the nuclear 
extracts of MCF-7 cell-lines treated with the AgNPs-CIT and 
PMA. As shown in Figure 7C, the pretreatment of cancer 
Figure 6 Gene and protein expression of TNFα. (A) Effect of AgNPs-CIT on PMA-induced gene expression of TNFα. Folds of TNFα mRNA expression as compared with 
control and normalized to GAPDH were determined by quantitative RT-PCR. (B) Effect of AgNPs-CIT on PMA-induced TNFα production in the culture medium of MCF-7 
cell lines. The production level of TNFα was determined by sandwich ELISA. Results are representative (mean ± standard error of the mean) of triplicate experiments. 
#p<0.001 versus untreated MCF-7 cells; @p<0.01 versus PMA alone treated MCF-7 cells.
Figure 7 Effect of AgNPs-CIT and BAY on PMA-induced NF-κB pathway in MCF-7 cells. (A) Effect of BAY 11–7082 on PMA-induced TNF-α mRNA expression. #p<0.01 
versus untreated MCF-7 cells, (B) Effect of BAY 11–7082 on PMA-induced TNF-α protein secretion in the culture medium of MCF-7 cells. @p<0.01 versus PMA alone 
treated MCF-7 cells, (C) Effect of AgNPs-CIT and BAY 11–7082 on PMA-induced NF-κB activation in the nuclear extract of MCF-7 cells. *p<0.05 versus PMA alone treated 
MCF-7 cells.
International Journal of Nanomedicine 2020:15                                                                          submit your manuscript | www.dovepress.com                                                                                                                                                                                                                       
DovePress                                                                                                                       
8487
Dovepress                                                                                                                                                       Abdellatif et al
cell-lines with the increasing concentrations of AgNPs-CIT 
significantly decreased the PMA-induced nuclear NF-κB p65 
levels (p<0.05) in the cancer cell-lines. The treatment of 
MCF-7 cell-lines with the BAY also significantly inhibited 
the NF-κB levels (p<0.01).
Discussion
The current study, for the first time, to the best of information, 
showed the AgNPs-CIT roles in inhibiting the PMA-induced 
TNFα production through deactivation of the NF-κB signal-
ing events in the human breast cancer cell-lines, MCF-7. The 
AgNPs-CIT was synthesized (Figure 8) according to the 
known method with some modifications.50
The silver nitrate aqueous solution is reduced by the TSC 
to produce nano-seeds through the process of electrons 
combining with the silver ion. The formed nano-seeds com-
bines together to produce the AgNPs-CIT which is hydrated 
around and covered with the citrate ions as part of the 
nanosilver stabilization, also represented as:
AgNO3 + H2O +Na3C6H5O7 →Ag+ + e− → Ag(NP 
seeds), Nucleation & Size growth + Stabilization → AgNPs- 
CIT
The FT-IR spectral analysis, together with electron 
micrography, confirmed the synthesis of AgNPs-CIT. In FT- 
IR analyses, a comparison showed peaks distinct from the 
TSC, AgNO3, and AgNPs-CIT. The mechanistic pathway 
yielding the AgNPs-CIT was confirmed by the presence of 
OH, and C=O peaks of the citrate moieties and the hydration 
covering of the product which are absent in the reducing 
agent TSC, and the starting material, AgNO3. The weak 
peak at 1400 cm−1 was also distinct for the product AgNPs- 
CIT and represented the methylenes bending of the citrate 
moieties which are exhibited in the TSC but are absent in the 
spectrum of AgNO3. These peaks and their comparative 
analysis indicated the steps in the reaction mechanism of 
the preparation of the AgNPs-CIT as confirmed by the FT-IR 
spectroscopy. The use of diluted silver ions concentration 
(mM range) as an aqueous solution of AgNO3, lessens the 
chances of produced nano silver aggregation and helps to 
control the sizing of the NPs. Other factor, such as, the 
temperature and pH also play crucial roles in the formation, 
sizing, charge, and the polydispersity of the nano 
preparation.51
The UV-VIS spectroscopy, a measurement of the 
absorption characteristic of the prepared nano entities is 
part of the critical technique for confirmation of the pre-
paration. The absorption wavelength is an indication of the 
size, reactivity, and the nature of the nano colloid.52,53 The 
prepared AgNPs-CIT exhibited distinctive absorption 
peaks between 381–452 nm, indicating the excitation of 
the surface plasmon, presumably, owing to the presence of 
free electrons which generate the resonance of the SPR 
band.44 The UV-VIS spectra of the AgNPs-CIT showed 
a gradual redshift, and the absorption peaks were attribu-
ted to the continuous increase in the sizes of the AgNPs- 
CIT overtime during the preparation. Steinigeweg et al54 
reported the synthesis of AgNPs-CIT, and therein the 
reaction was much faster as indicated by the rapid color 
changes of the reaction medium. The color changes were 
indicated by the changes in the absorption wavelengths of 
the nano preparations. Also, the maximum wavelength 
shifts of the absorption band occur due to the increase in 
the diameter of the nanospheroids.55 Ranoszek-Soliwoda 
et al,44 also observed the absorption band maxima (λmax) 
at 432 nm when the synthesis was carried out at 100 °C, 
indicating the role of temperature in the synthesis and size- 
controls of the NPs. The size of the nanoparticle changes 
upon continuous energy supply to the reacting media, 
duration of the reaction, parameters of pH, variations in 
the concentrations of the reacting components as well as 
dilutions of the solvent/reacting media during the synth-
esis, the speed, and duration of the stirring/agitation which 
Figure 8 Schematic representation of the reaction mechanism of the silver nanoparticles formation: (A) Silver Nitrate (AgNO3), (B). Tri-Sodium Citrate (TSC), (C). Water 
Molecules, (D). Silver ions, (E). Electron, (F). Nano-seeds (primitive nanoparticles). (G). Nucleation, aggregation of smaller nano-seeds, (H). Nanoparticle stabilization by 
citrate ions.
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is also another source of energy than the heating of the 
reaction media (which may or may not be present in 
a particular synthesis), temperature maintenance and its 
up-scaling during the synthesis, intermolecular distances 
between the reacting components, formed nuclei, NPs, 
solvent molecules, and other components in the reacting 
pot, ie, presence of catalysts, biogenic materials from 
plants or other natural sources, synthetic entities as co- 
catalyst, and facilitators of the synthesis, present during 
the synthetic process. The morphology and charges on the 
nano preparation colloids are also variables through these 
parameters of change.55
During the current preparations, the particle sizes were 
observed to be increased which reflected the roles of 
various factors involved during the synthesis. The changes 
in the particle sizes were indicated by the color changes of 
the preparations, observed at different time intervals, ie, 2, 
4, 6, 8, 10, and 12 min (Figure 1). The color changes of the 
preparations at different time intervals, the sizes of the 
NPs in the preparation at the specific time, and the UV- 
VIS absorption spectra of the colored solutions obtained at 
specific times were recorded and found to be between 381 
and 452 nm range. Moreover, the nanoparticle sizing is 
also a function of the concentration of the reacting raw 
materials, and the silver ion source, ie, AgNO3 concentra-
tion, as well as the presence and concentrations of the 
ionic molds, eg, citrate ions, as the anionic component in 
the aqueous medium, which also played the part in decid-
ing the NPs sizes.56 The relation between the size and 
color of the NPs was also reported by Fuku et al45 who 
outlined that the colors of all plasmonic NPs can be altered 
by varying the size and morphology of the particles which 
is reflected in the changes in the SPR absorption wave-
lengths of the particles. The blue and redshifts in the 
absorptions are observed based on the reduction and incre-
ments in the NPs sizes.45,56
Moreover, the electronic images reflect the metallic 
center of the particles as they capture the core of the NPs 
after the surrounding hydrated area of the metal core 
(also containing citrate in AgNPs-CIT) is collapsed/ 
removed during the sample preparation and image pro-
curement processes for the electronic imaging, including 
the SEM high-vacuum chamber,57 and is the reason 
behind the size differences with the other size measure-
ment technique, ie, DLS technique. The sizes of the 
AgNPs-CIT NPs were recorded by the DLS and have 
shown the size difference owing to different techniques. 
Our interpretation is in agreement with the size recorded 
with DLS, and the particle diameters from DLS are 
lower than those obtained from SEM imaging which is 
considered to be due to the presence of the citrate coat-
ing of the AgNPs-CIT, and this also limits the total 
particle density. The DLS estimates the average sizes 
of the NPs which are not the same and varies signifi-
cantly from the sizes measured by the SEM technique. 
The DLS based average size estimations of the AgNPs- 
CIT suspension may also vary and at times may not be 
reproducible wherein the nanosuspension may aggregate 
and affect the average distribution of size.58
The presence of citrate anions frames in the preparation 
media works as scaffoldings that are adsorbed on the 
surfaces of the generating NPs. The prepared AgNPs-CIT 
were overwhelmingly negatively charged as observed in 
the ζ-potential measurements. Their charges varied from 
−9.99±0.8 to −34.63±0.1 mV with changes in size and 
colors. The high negative ζ-potential of the red-colored 
AgNPs-CIT indicated that the particles are of the highest 
electrically stabilized nature to resist aggregation. Similar 
results were also reported by Greenwood et al, 59, and 
Moraes et al,60 who reported that the size, PDI, and ζ- 
potential are parameters that indicate the stability of NPs. 
Kaufman et al,49 stated that the surface charges upon NPs 
play significant roles in the stabilization of the NPs, 
whereas the degrees of ζ-potential is a parameter of the 
colloidal stability of the system. The PDI, considered as an 
indication of the near homogeneity of the particles’ sizes 
in the sample of the NPs, are interpreted as, if the PDIs is 
lower than 0.2, the particle size distribution falls within 
a narrow range of sizes,61 and is considered ideal. Also, 
there are particles aggregation and size increase which 
leads to a reduction in ζ-potentials of the last two samples 
(−23.5±0.9, and −9.99±0.8 mV) obtained at 10 and 12 min 
of the preparation with higher sizes (120.67±0.11, and 
220.77±0.12 nm, DLS), and high UV-VIS absorbance 
values at 440±3.5, and 452±1.5 nm, respectively. These 
results are in agreement with Guang Lu et al observations 
on the ζ-potential values that explained that distinct stabi-
lity can be expected around (+10)-(−10) mV ζ-potential 
values. Other considerations, such as reduced size have 
also played a significant role in stabilizing the NPs.62
The antioxidants are useful in quenching and minimiz-
ing the effects of excessively generated free radicals in the 
human body which can destroy the cell components, cause 
permanent cell damages, and eventual cell death. It plays 
havoc with the lipids, proteins, and DNA, leading to 
cancers and other diseases. The antioxidant activity 
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evaluation of the AgNPs-CIT showed noticeable anti 
oxidant activity at about 40% inhibitions of the DPPH 
radicals when compared with the hydrogen peroxide and 
quercetin (Figure 4). The antioxidant activity of AgNPs- 
CIT was attributed to the surface-presence of the citrate 
molds on the AgNPs-CIT.63 Akhtar et al48 concluded that 
the antioxidant efficacy of AgNPs could be acknowledged 
to the probable adsorption of coating layer around AgNPs 
of various phytochemicals e.g; polyphenols, flavonoids, 
saponins, terpenoids, and vitamins which is the cause of 
strong antioxidant activity of the phytochemicals sup-
ported NPs synthesis. In the case of the present synthesis, 
the moderate antioxidant activity is due to the presence of 
citrate moieties around the AgNPs.
The AgNPs-CIT showed no toxicity to the breast cancer 
cell-lines, MCF-7, as determined by CytoTox-Glo™ 
Cytotoxicity assays. The concentrations used in these assays 
were in conformity with the procedure and results reported 
by Yingying et al.5 The cytotoxicity evaluations showed that 
cell proliferation of MCF-7 cell-lines, after treatment with 
AgNPs-CIT, was termination as observed in the incubation 
of MCF-7 cell-lines with AgNPs-CIT for 24 and 48 h. The 
extent of PMA-induced proliferation was significantly 
decreased when the MCF-7 cell-lines were first treated with 
AgNPs-CIT. The cells pretreated with 5 and 10 μM doses of 
AgNPs-CIT for 48 h highlighted the proliferation of AgNPs- 
CIT treated MCF-7 cell lines. Importantly, no cytotoxic 
effects of AgNPs-CIT were observed at the levels of the 
administered dose. Moreover, the levels of TNFα mRNA 
production were assayed by the quantitative RT-PCR 
method, and the results showed that the MCF-7 cell-lines 
incubated with PMA had higher levels of TNFα mRNA as 
compared to the non-stimulated MCF-7 cell-lines. The TNFα 
mRNA levels showed a marked decline.
The activation of the master transcription factor, NF-κB, 
leads to coordinated expression of many genes that encode 
cytokines, chemokines, enzymes, and adhesion molecules 
involved in mediator synthesis, and further amplification and 
perpetuation of the inflammatory reactions.37 The expression 
of the TNF-α gene is dependent on the activation of transcrip-
tion factor NF-κB.41 Because the suppression of NF-κB acti-
vation has been linked with anti-inflammatory activity, it was 
postulated that the silver ions from AgNPs-CIT mediate its 
inhibitory effects on TNFα expressions, at least in part, 
through the suppression of the NF-κB activity. The activation 
of NF-κB requires proteolytic degradation of the inhibitory 
protein IκBα, an endogenous inhibitor, that binds to NF-κB in 
the cytoplasm, and its degradation exposes the nuclear 
localization signal and allows the NF-κB to translocate to the 
nucleus and binds with the promoter of the target genes.37,41 In 
PMA-stimulated MCF-7 cell-lines, the AgNPs-CIT inhibit the 
nuclear translocation of the p65 NF-κB. These results were 
further confirmed by the treatment of cancer cell-lines with 
BAY-11, a well-known inhibitor of NF-κB activity.39 These 
data indicate that the AgNPs-CIT significantly decreased the 
PMA stimulated inflammatory gene expression and produc-
tion of TNF-α in MCF-7 breast cancer cell-lines. The inhibi-
tory effect of silver nanoparticles on the pro-inflammatory 
cytokine, TNF-α, was NF-κB dependent. The inhibitory 
effects of the AgNPs-CIT on MCF-7 cell-lines differentiation 
at higher doses was attributed to the increased concentrations 
of the AgNPs-CIT.
Conclusions
The synthesized AgNPs-CIT were characterized through 
physicochemical methods, and the antioxidant assays of 
the NPs showed moderate levels of reactive oxygen spe-
cies radical scavenging activity of the DPPH against the 
quercetin. The synthesized AgNPs-CIT were sufficiently 
stable in the physiological conditions to demonstrate its 
bioactivity in the designated activity environment. The 
AgNP-CIT worked as an inhibitor of PMA-induced acti-
vation of NF-κB signalings as well as an inhibitor of the 
TNF-α productions at significant levels which corrobo-
rated the hypothesis on the cancer suppression through 
signaling manipulation by physiological and biochemical 
means and pathways. Observations also confirmed the 
roles of the physiological pathways in the tumor progres-
sion and provided a confirmatory route to suppress the 
tumor growth through cutting-short the signaling pathway. 
These findings upload significant future roles in finding 
new clinical entities and approaches for cancer prevention 
and treatments. The study may also provide an alternative 
strategy for further adjudication of AgNPs-CIT as part of 
a chemotherapeutic regimen for TNF-α produced breast 
cancer’s safe and potent treatment.
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